Functional Dyspepsia and Eradication Therapy of Helicobacter Pylori

LIU Xinguang
DOI: https://doi.org/10.3969/j.issn.1008-7125.2008.03.003
2008-01-01
Abstract:Nearly all Helicobacter pylori(H.pylori) positive functional dyspepsia(FD) or non-ulcer dyspepsia(NUD) patients have the histopathological changes of the chronic and/or acute active gastric mucosal inflammation,making it difficult to differentiate from chronic gastritis and influencing the study of H.pylori eradication therapy in FD patients.The Rome Ⅲ diagnostic criteria of FD is based mainly on symptomatology,and it only occurs in a susceptible population with psychological modulatory hindrance.Patients have visceral hypersensitivity,dysfunction of brain-gut axis,secretory abnormalities of some neural mediators and neuropeptides;and hereditary predisposition has been observed.H.pylori eradication therapy might be helpful in some of the H.pylori infected FD patients and could be recommended after careful evaluation of the benefit and risk in individual patient.
What problem does this paper attempt to address?